GET THE APP

..

Journal of Diabetic Complications & Medicine

ISSN: 2475-3211

Open Access

Citations Report

Journal of Diabetic Complications & Medicine : Citations & Metrics Report

Articles published in Journal of Diabetic Complications & Medicine have been cited by esteemed scholars and scientists all around the world.

Journal of Diabetic Complications & Medicine has got h-index 6, which means every article in Journal of Diabetic Complications & Medicine has got 6 average citations.

Following are the list of articles that have cited the articles published in Journal of Diabetic Complications & Medicine.

  2024 2023 2022 2021 2020 2019 2018

Total published articles

40 25 32 30 23 3 6

Research, Review articles and Editorials

4 1 2 7 17 0 6

Research communications, Review communications, Editorial communications, Case reports and Commentary

36 24 30 23 6 0 0

Conference proceedings

0 15 51 23 0 15 37

Citations received as per Google Scholar, other indexing platforms and portals

127 89 16 18 13 13 7
Journal total citations count 102
Journal impact factor 2.05
Journal 5 years impact factor 0.74
Journal cite score 2.71
Journal h-index 6
Journal h-index since 2019 4
Important citations

Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes

Stimulation of Hepatocyte Glucose Metabolism by Novel Small Molecule Glucokinase Activators

Narrative Review: A Rational Approach to Starting Insulin Therapy

Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretion

A Rational Approach to Drug Therapy of Type 2 Diabetes Mellitus

Metformin Effects on Dipeptidylpeptidase IV Degradation of Glucagon-like Peptide-1

Meglitinide analogues for type 2 diabetes mellitus

SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats

PPAR-? agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis

Is There a Role for ?-Glucosidase Inhibitors in the Prevention of Type 2 Diabetes Mellitus?

Is There a Role for ?-Glucosidase Inhibitors in the Prevention of Type 2 Diabetes Mellitus?

Is There a Role for ?-Glucosidase Inhibitors in the Prevention of Type 2 Diabetes Mellitus?

Improving glucose management: Ten steps to get more patients with type 2 diabetes to glycaemic goal Recommendations from the Global Partnership for Effective Diabetes Management

Anti-diabetic effect of ginsenoside Re in ob/ob mice

Effect of Genetic Polymorphisms in Cytochrome P450 (CYP) 2C9 and CYP2C8 on the Pharmacokinetics of Oral Antidiabetic Drugs

Effects of Oral Administration of Moringa oleifera Lam on Glucose Tolerance in Goto-Kakizaki and Wistar Rats

Repaglinide A Review of its Therapeutic Use in Type 2 Diabetes Mellitus

Inhibitory potential of trilobatin from Lithocarpus polystachyus Rehd against ?-glucosidase and ?-amylase linked to type 2 diabetes

Metformin Rapidly Increases Insulin Receptor Activation in Human Liver and Signals Preferentially through Insulin-Receptor Substrate-2

Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity

arrow_upward arrow_upward